One study profiled 192 ATRT tumours and identified 3 tumours that showed retained SMARCB1 expression, with all 3 of these tumours carrying a mutation in SMARCA4 and clustering in the SHH-subgroup of ATRT [33]. The gene discussed is SMARCB1; the disease is neoplasm.